These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 26383125

  • 21. Synthesis and antileishmanial evaluation of 1-aryl-4-(4,5-dihydro-1H-imidazol-2-yl)-1H-pyrazole derivatives.
    dos Santos MS, Oliveira ML, Bernardino AM, de Léo RM, Amaral VF, de Carvalho FT, Leon LL, Canto-Cavalheiro MM.
    Bioorg Med Chem Lett; 2011 Dec 15; 21(24):7451-4. PubMed ID: 22055204
    [Abstract] [Full Text] [Related]

  • 22. Synthesis and antileishmanial activity of 5-(5-nitroaryl)-2-substituted-thio-1,3,4-thiadiazoles.
    Alipour E, Emami S, Yahya-Meymandi A, Nakhjiri M, Johari F, Ardestani SK, Poorrajab F, Hosseini M, Shafiee A, Foroumadi A.
    J Enzyme Inhib Med Chem; 2011 Feb 15; 26(1):123-8. PubMed ID: 20578974
    [Abstract] [Full Text] [Related]

  • 23. Effectiveness of novel 5-(5-amino-1-aryl-1H-pyrazol-4-yl)-1H-tetrazole derivatives against promastigotes and amastigotes of Leishmania amazonensis.
    dos Santos Faiões V, Leon LL, Canto-Cavalheiro MM, Torres-Santos EC, Bernardino AM, Vegi PF, dos Santos MS.
    Chem Biol Drug Des; 2014 Mar 15; 83(3):272-7. PubMed ID: 24119090
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series.
    Kieffer C, Cohen A, Verhaeghe P, Hutter S, Castera-Ducros C, Laget M, Remusat V, M'Rabet MK, Rault S, Rathelot P, Azas N, Vanelle P.
    Eur J Med Chem; 2015 Mar 06; 92():282-94. PubMed ID: 25559208
    [Abstract] [Full Text] [Related]

  • 32. Potency switch between CHK1 and MK2: discovery of imidazo[1,2-a]pyrazine- and imidazo[1,2-c]pyrimidine-based kinase inhibitors.
    Meng Z, Ciavarri JP, McRiner A, Zhao Y, Zhao L, Reddy PA, Zhang X, Fischmann TO, Whitehurst C, Arshad Siddiqui M.
    Bioorg Med Chem Lett; 2013 May 15; 23(10):2863-7. PubMed ID: 23587425
    [Abstract] [Full Text] [Related]

  • 33. 2,6,9-Trisubstituted purines as CRK3 kinase inhibitors with antileishmanial activity in vitro.
    Řezníčková E, Popa A, Gucký T, Zatloukal M, Havlíček L, Bazgier V, Berka K, Jorda R, Popa I, Nasereddin A, Jaffe CL, Kryštof V, Strnad M.
    Bioorg Med Chem Lett; 2015 Jun 01; 25(11):2298-301. PubMed ID: 25937014
    [Abstract] [Full Text] [Related]

  • 34. Structure based design of novel 6,5 heterobicyclic mitogen-activated protein kinase kinase (MEK) inhibitors leading to the discovery of imidazo[1,5-a] pyrazine G-479.
    Robarge KD, Lee W, Eigenbrot C, Ultsch M, Wiesmann C, Heald R, Price S, Hewitt J, Jackson P, Savy P, Burton B, Choo EF, Pang J, Boggs J, Yang A, Yang X, Baumgardner M.
    Bioorg Med Chem Lett; 2014 Oct 01; 24(19):4714-4723. PubMed ID: 25193232
    [Abstract] [Full Text] [Related]

  • 35. Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines.
    Khan I, Zaib S, Ibrar A, Rama NH, Simpson J, Iqbal J.
    Eur J Med Chem; 2014 May 06; 78():167-77. PubMed ID: 24681981
    [Abstract] [Full Text] [Related]

  • 36. Chromene-based synthetic chalcones as potent antileishmanial agents: synthesis and biological activity.
    Foroumadi A, Emami S, Sorkhi M, Nakhjiri M, Nazarian Z, Heydari S, Ardestani SK, Poorrajab F, Shafiee A.
    Chem Biol Drug Des; 2010 Jun 06; 75(6):590-6. PubMed ID: 20337782
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of antileishmanial activity of eupomatenoid-5, a compound isolated from leaves of Piper regnellii var. pallescens.
    Vendrametto MC, Santos AO, Nakamura CV, Dias Filho BP, Cortez DA, Ueda-Nakamura T.
    Parasitol Int; 2010 Jun 06; 59(2):154-8. PubMed ID: 20064628
    [Abstract] [Full Text] [Related]

  • 38. Dihydropyrido[2,3-d]pyrimidines as a new class of antileishmanial agents.
    Agarwal A, Ramesh, Ashutosh, Goyal N, Chauhan PM, Gupta S.
    Bioorg Med Chem; 2005 Dec 15; 13(24):6678-84. PubMed ID: 16126395
    [Abstract] [Full Text] [Related]

  • 39. Synthesis, characterization, and antileishmanial activity of neutral N-heterocyclic carbenes gold(I) complexes.
    Zhang C, Bourgeade Delmas S, Fernández Álvarez Á, Valentin A, Hemmert C, Gornitzka H.
    Eur J Med Chem; 2018 Jan 01; 143():1635-1643. PubMed ID: 29133045
    [Abstract] [Full Text] [Related]

  • 40. Palladium catalyzed one-pot sequential Suzuki cross-coupling-direct C-H functionalization of imidazo[1,2-a]pyrazines.
    Gembus V, Bonfanti JF, Querolle O, Jubault P, Levacher V, Hoarau C.
    Org Lett; 2012 Dec 07; 14(23):6012-5. PubMed ID: 23151283
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.